comparemela.com

Latest Breaking News On - Melinda baker - Page 7 : comparemela.com

Ascendis Pharma s Initial Dose Escalation Results from the Ongoing Phase 1/2 Trial of TransCon™ IL-2 β/γ Accepted for Online Publication at ASCO 2023

COPENHAGEN, Denmark, April 03, 2023 Ascendis Pharma A/S today announced that initial dose escalation data from the Company’s ongoing Phase 1/2 IL-Believe Trial of TransCon IL-2. | April 3, 2023

Ascendis Pharma Provides Update on Vision 3x3 Strategic Roadmap at 41st Annual J P Morgan Healthcare Conference

–   On track to fulfill all elements of Vision 3x3 to build a sustainable, profitable, leading biopharma company COPENHAGEN, Denmark, Jan. 08, 2023 Ascendis Pharma A/S today. | January 8, 2023

vimarsana © 2020. All Rights Reserved.